Delivery Order SPE2DB20D3103-SPE2DB23FP3B6

Award Date 8/9/23
Potential Completion Date 8/10/23
Potential Value $9.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,995.03, is for the delivery of Entecavir 0.5 mg tablets. The contract is a firm-fixed price arrangement with an ultimate completion date of June 18, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,483.84, is for the delivery of the pharmaceutical product Entecavir 0.5 mg Tablet 30s. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The award is for the supply of Entecavir 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $1,575.35 and a completion date of August 1, 2024. This order is issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,955.08 contract is for the supply of Entecavir 0.5mg tablets. It is a firm-fixed-price contract with a period of performance through February 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4562359045 - Entecavir 0.5 mg Tablet 30s. The $1,916.41 firm fixed price delivery order has an ultimate completion date of October 2, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Entecavir 0.5mg tablets. The contract, valued at $7,808.22, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award has a ceiling value of $3,954.80 and a completion date of August 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,652.64, is for the delivery of Entecavir 0.5 mg Tablets, a medication used to treat chronic hepatitis B. The contract is a firm fixed price delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,341.22, is for the delivery of Entecavir 0.5 mg tablets. It is a firm fixed-price contract with a period of performance through May 21, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order issued under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,980.54 firm-fixed-price contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat hepatitis B. The contract has an ultimate completion date of June 28, 2023 and was awarded on June 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP3B6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,179.16, is for the delivery of Entecavir 0.5 mg tablets, a prescription medication. The contract has a completion date of August 10, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation mentioned for this specific award.

Generated 2/27/25, 12:45 PM